AMED Stock Overview
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Amedisys, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$91.94 |
| 52 Week High | US$179.91 |
| 52 Week Low | US$79.30 |
| Beta | 1.0 |
| 1 Month Change | 11.31% |
| 3 Month Change | 8.68% |
| 1 Year Change | -31.94% |
| 3 Year Change | -52.88% |
| 5 Year Change | 67.07% |
| Change since IPO | 1,651.23% |
Recent News & Updates
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Recent updates
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Apr 14Is Amedisys (NASDAQ:AMED) Using Too Much Debt?
Apr 01Is Amedisys (NASDAQ:AMED) A Future Multi-bagger?
Mar 19Bruce Perkins Is The Independent Director of Amedisys, Inc. (NASDAQ:AMED) And They Just Picked Up 3.7% More Shares
Mar 06Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Feb 20
Shareholders Are Raving About How The Amedisys (NASDAQ:AMED) Share Price Increased 730%
Feb 08How Much Are Amedisys, Inc. (NASDAQ:AMED) Insiders Spending On Buying Shares?
Jan 26Are Robust Financials Driving The Recent Rally In Amedisys, Inc.'s (NASDAQ:AMED) Stock?
Jan 13Shareholder Returns
| AMED | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -4.9% | -4.4% | 0.9% |
| 1Y | -31.9% | -7.2% | -10.9% |
Return vs Industry: AMED underperformed the US Healthcare industry which returned -7.2% over the past year.
Return vs Market: AMED underperformed the US Market which returned -10.9% over the past year.
Price Volatility
| AMED volatility | |
|---|---|
| AMED Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 7.7% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: AMED is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: AMED's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 21,000 | Paul Kusserow | https://www.amedisys.com |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Amedisys, Inc. Fundamentals Summary
| AMED fundamental statistics | |
|---|---|
| Market Cap | US$2.93b |
| Earnings (TTM) | US$120.94m |
| Revenue (TTM) | US$2.22b |
24.7x
P/E Ratio1.3x
P/S RatioIs AMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMED income statement (TTM) | |
|---|---|
| Revenue | US$2.22b |
| Cost of Revenue | US$1.24b |
| Gross Profit | US$980.03m |
| Other Expenses | US$859.09m |
| Earnings | US$120.94m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 15, 2023
| Earnings per share (EPS) | 3.72 |
| Gross Margin | 44.14% |
| Net Profit Margin | 5.45% |
| Debt/Equity Ratio | 42.4% |
How did AMED perform over the long term?
See historical performance and comparison